<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/"><channel><title>药春秋 | wechat-feeds</title><link>http://MzI0MDM2NTA4NQ.favicon.privacyhide.com/favicon.ico</link><description>医药行业一致性评价工作在如火如荼的进行中，作为行业的一份子，愿本愚公之念，出蝼蚁 之力，献寸光之策。</description><managingEditor> (hellodword)</managingEditor><pubDate>Fri, 19 Mar 2021 23:18:45 +0800</pubDate><image><url>http://MzI0MDM2NTA4NQ.favicon.privacyhide.com/favicon.ico</url><title>药春秋 | wechat-feeds</title><link>http://MzI0MDM2NTA4NQ.favicon.privacyhide.com/favicon.ico</link><width>64</width><height>64</height></image><item><title>盘点重磅多肽品种，千亿市场正嗷嗷待哺！</title><link>https://mp.weixin.qq.com/s/-4jLuoSIiy4ltSgLD6KWeg</link><description></description><content:encoded><![CDATA[盘点重磅多肽品种，千亿市场正嗷嗷待哺！]]></content:encoded><pubDate>Fri, 19 Mar 2021 21:42:16 +0800</pubDate></item><item><title>人福药业：一国家短缺药，涨价53%出售！</title><link>https://mp.weixin.qq.com/s/TYJK1YHEkxFec-_DaoLMBA</link><description></description><content:encoded><![CDATA[人福药业：一国家短缺药，涨价53%出售！]]></content:encoded><pubDate>Fri, 19 Mar 2021 21:42:16 +0800</pubDate></item><item><title>两年无采购记录，取消挂网！</title><link>https://mp.weixin.qq.com/s/jDXSi4fxuF7rPqJ9mUE2dg</link><description></description><content:encoded><![CDATA[两年无采购记录，取消挂网！]]></content:encoded><pubDate>Fri, 19 Mar 2021 21:42:16 +0800</pubDate></item><item><title>注意！4个注射剂价格异常，需调查</title><link>https://mp.weixin.qq.com/s/XOE3gvx7eO1pMl8IBgrONA</link><description></description><content:encoded><![CDATA[注意！4个注射剂价格异常，需调查]]></content:encoded><pubDate>Fri, 19 Mar 2021 21:42:16 +0800</pubDate></item><item><title>一致性评价新动态：普利制药收获2首家过评品种！</title><link>https://mp.weixin.qq.com/s/yGJvMqc1XwvM8Sp9lcMWLQ</link><description></description><content:encoded><![CDATA[一致性评价新动态：普利制药收获2首家过评品种！]]></content:encoded><pubDate>Thu, 18 Mar 2021 21:42:50 +0800</pubDate></item><item><title>4个药品降价挂网，降幅高达74%！</title><link>https://mp.weixin.qq.com/s/TwedyLtlPF7momUSuwzrVQ</link><description></description><content:encoded><![CDATA[4个药品降价挂网，降幅高达74%！]]></content:encoded><pubDate>Thu, 18 Mar 2021 21:42:50 +0800</pubDate></item><item><title>带量采购新玩法，采购量：原研药＞过评药＞非过评药？！</title><link>https://mp.weixin.qq.com/s/DkvAsE4LMXtutnun2LI0jw</link><description></description><content:encoded><![CDATA[带量采购新玩法，采购量：原研药＞过评药＞非过评药？！]]></content:encoded><pubDate>Thu, 18 Mar 2021 21:42:50 +0800</pubDate></item><item><title>《药品注册管理办法》热点问题答疑</title><link>https://mp.weixin.qq.com/s/zK0X_6d6g0qn83evV2ruNA</link><description></description><content:encoded><![CDATA[《药品注册管理办法》热点问题答疑]]></content:encoded><pubDate>Thu, 18 Mar 2021 21:42:50 +0800</pubDate></item><item><title>第五批国采在路上，这些重点值得关注！</title><link>https://mp.weixin.qq.com/s/kViW-mhCT1-WSK3aBFYOlw</link><description></description><content:encoded><![CDATA[第五批国采在路上，这些重点值得关注！]]></content:encoded><pubDate>Wed, 17 Mar 2021 21:36:27 +0800</pubDate></item><item><title>一大批药品价格存疑，涉及天晴、石药、信立泰等企业</title><link>https://mp.weixin.qq.com/s/FCYCr5Yt87fKRaUBG_SaSg</link><description></description><content:encoded><![CDATA[一大批药品价格存疑，涉及天晴、石药、信立泰等企业]]></content:encoded><pubDate>Wed, 17 Mar 2021 21:36:27 +0800</pubDate></item><item><title>超5000个品种暂停销售，原因竟是...</title><link>https://mp.weixin.qq.com/s/iaGQX30WQnsV6bGShdD4SQ</link><description></description><content:encoded><![CDATA[超5000个品种暂停销售，原因竟是...]]></content:encoded><pubDate>Wed, 17 Mar 2021 21:36:27 +0800</pubDate></item><item><title>这些抗癌药降价了！</title><link>https://mp.weixin.qq.com/s/fRaGYQCpHAP464T4P00Izg</link><description></description><content:encoded><![CDATA[这些抗癌药降价了！]]></content:encoded><pubDate>Wed, 17 Mar 2021 21:36:27 +0800</pubDate></item><item><title>（2021.3.16）最新过评名单，4品种决出首家！</title><link>https://mp.weixin.qq.com/s/lBmZVSdszCyIp0vE6DXDLw</link><description></description><content:encoded><![CDATA[（2021.3.16）最新过评名单，4品种决出首家！]]></content:encoded><pubDate>Tue, 16 Mar 2021 21:40:22 +0800</pubDate></item><item><title>“小身材、大潜力”-厄他培南，3亿国内市场在持续迸发...</title><link>https://mp.weixin.qq.com/s/YzuzHrCdb4OQfeecUsdSyQ</link><description></description><content:encoded><![CDATA[“小身材、大潜力”-厄他培南，3亿国内市场在持续迸发...]]></content:encoded><pubDate>Tue, 16 Mar 2021 21:40:22 +0800</pubDate></item><item><title>CDE：皮肤外用仿制药，有了新技术指导原则！</title><link>https://mp.weixin.qq.com/s/YHERuz7ryOniFvF9yh0ZoQ</link><description></description><content:encoded><![CDATA[CDE：皮肤外用仿制药，有了新技术指导原则！]]></content:encoded><pubDate>Tue, 16 Mar 2021 21:40:22 +0800</pubDate></item><item><title>佰药云—注册代理服务</title><link>https://mp.weixin.qq.com/s/mjv12h4d91T5hl8JHnWopQ</link><description></description><content:encoded><![CDATA[佰药云—注册代理服务]]></content:encoded><pubDate>Tue, 16 Mar 2021 21:40:22 +0800</pubDate></item><item><title>17个品种！第二批鼓励仿制药目录发布</title><link>https://mp.weixin.qq.com/s/lmEOJNsxXdiUzkEVF0lF-A</link><description></description><content:encoded><![CDATA[17个品种！第二批鼓励仿制药目录发布]]></content:encoded><pubDate>Tue, 16 Mar 2021 21:40:22 +0800</pubDate></item><item><title>2月一致性评价：申报量回落，17品种首家过评…</title><link>https://mp.weixin.qq.com/s/zC2C7Oas0JEjhsgxcKwZpQ</link><description></description><content:encoded><![CDATA[2月一致性评价：申报量回落，17品种首家过评…]]></content:encoded><pubDate>Mon, 15 Mar 2021 21:41:32 +0800</pubDate></item><item><title>二甲双胍再现新功效</title><link>https://mp.weixin.qq.com/s/TcoNSrk29K7NzZx56p5izQ</link><description></description><content:encoded><![CDATA[二甲双胍再现新功效]]></content:encoded><pubDate>Mon, 15 Mar 2021 21:41:32 +0800</pubDate></item><item><title>关于新版基药目录调整，看看人大代表怎么说？</title><link>https://mp.weixin.qq.com/s/blvJASt4oPdNxZa408MdCQ</link><description></description><content:encoded><![CDATA[关于新版基药目录调整，看看人大代表怎么说？]]></content:encoded><pubDate>Mon, 15 Mar 2021 21:41:32 +0800</pubDate></item></channel></rss>